James Moon MD, MRCP, MB BCh

Dr. Moon is currently professor of Cardiology at UCL IRIS - University College London. He Has received MD, MRCP, MB BCh, BA degrees from University of London, Royal College Of Physicians, University Of Oxford, University Of Cambridge.His main interest is in measuring and defining normal and abnormal myocardium using advanced cardiac imaging (MRI, CT, echo) and working with basic science (genetics/proteomics) and with drug developers aiming for better patient care and better patient outcomes. Particular disease of interest are: infiltration (amyloid, fabrys), cardiomyopathy (inherited and acquired), diffuse fibrosis , valvular heart disease, health (normal, athletes, veteran athletes, post training).

His publications are as follows:
Moon, J. C., Messroghli, D. R., Kellman, P., Piechnik, S. K., Robson, M. D., Ugander, M., . . . Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. (2013). Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 15, 92-?. doi:10.1186/1532-429X-15-92.
Flett, A. S., Hayward, M. P., Ashworth, M. T., Hansen, M. S., Taylor, A. M., Elliott, P. M., . . . Moon, J. C. (2010). Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation, 122 (2), 138-144. doi:10.1161/CIRCULATIONAHA.109.930636.
O'Hanlon, R., Grasso, A., Roughton, M., Moon, J. C., Clark, S., Wage, R., . . . Prasad, S. K. (2010). Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol, 56 (11), 867-874. doi:10.1016/j.jacc.2010.05.010 .
Moon, J. C., & Bogle, R. G. (2006). Switching statins. BMJ, 332 (7554), 1344-1345. doi:10.1136/bmj.332.7554.1344.
Moon, J. C., Fisher, N. G., McKenna, W. J., & Pennell, D. J. (2004). Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart, 90 (6), 645-649.
Highlighted publicationMoon, J. C., Reed, E., Sheppard, M. N., Elkington, A. G., Ho, S. Y., Burke, M., . . . Pennell, D. J. (2004). The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopath.